Brief: AnaptysBio Q1 Net Income USD -43.936 Million
09/05/2024 21:15
May 09 (Reuters) - AnaptysBio Q1 operating expenses USD 49.38 million. * Q1 collaboration revenue USD 7.179 million * Q1 income from operations USD -42.201 million
Recent news on AnaptysBio
See all newsFirst Tracks Biotherapeutics up after $200 mln equity raise
US RESEARCH ROUNDUP-Alnylam Pharmaceuticals, Carvana, MongoDB
US RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
Brief: Anaptys Announces Second Quarter And Transitional Fiscal Year 2026 Financial Results And Provides Business Update
AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties